GLP-1 Drugs Show Promise in Cancer Prevention, Researchers Investigate Mechanisms

Executive Briefing

• Reveal studies suggesting GLP-1 drugs like semaglutide and tirzepatide may prevent cancer and slow its progression
• Indicate weight loss alone does not fully explain the protective effect, pointing to broader metabolic pathways
• Suggest GLP-1s may act on brain and metabolic systems beyond glucose regulation to reduce cancer risk
• Highlight ongoing research presented at ASCO aimed at understanding the biological mechanisms behind these findings